Alivus Life Sciences Ltd.
ALIVUS Share PricePharmaceuticals & Drugs
₹915.05
24.5 (2.8%)
As on November 7, 2025
Exchange Scrips: BSE543322NSEALIVUSISININE03Q201024
Market Cap ₹ 10,919 Cr
P/E Ratio 22.47
Dividend Yield 0.28 %
Performance
Market performance
Open925
High932
Volumes1,58,323
Prev915.05
Low903.9
As on2025-11-07
Historical performance
1 Year High1,251
3 Year High1,335.1
5 Year High1,335.1
1 Year Low850
3 Year Low370
5 Year Low370
Fundamentals
Company Valuation
Market Cap (₹Cr)
10,919
Face Value (₹)
2
P/E Ratio
22.47
Dividend Yield
0.28 %
Investment Returns
1 Year
-18.1%
3 Years
109.6%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 906.4 | Bullish |
| 10-DMA | 909.73 | Bullish |
| 20-DMA | 918.64 | Bearish |
| 50-DMA | 936 | Bearish |
| 100-DMA | 970.25 | Bearish |
| 200-DMA | 1,020.21 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 1 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 1 | 1 | 1 | 1 | 1 |
| Public Investors | 135642 | 138499 | 141976 | 146839 | 143959 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 22.47.
- 3Y Stock Price CAGR of the stock is 26.8.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹7172 Million.
- The company generated revenue of ₹23869 Million in the previous financial year.
Alivus Life Sciences Ltd.
915.0524.5 (2.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 834823.5
No. of Shares: 912 (Approx)
Performance:-16.5%
P/L: ₹-165176.5
Top Gainers
Top Losers
| Symbol | Change% |
|---|---|
| BLISSGVS | 127.9(-16%) |
| SILLYMONKS | 23(-12%) |
| RSSOFTWARE | 57.21(-10%) |
| SAATVIKGL | 490.25(-9%) |
| VENKEYS | 1391.6(-9%) |
| AMBER | 7227(-8%) |
| LATENTVIEW | 436.55(-7%) |
| DCAL | 248.85(-7%) |
Peer Comparison
Get Your Portfolio Reviewed
